iconiifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

KIMS Hospital to acquire majority 51% stake in Kingsway Hospitals, Nagpur

30 Aug 2022 , 09:23 AM

Krishna Institute of Medical Sciences (KIMS) revealed that it has entered into a formal agreement to buy a majority stake of 51% in M/s SPANV Medisearch Lifesciences Private Limited, Nagpur, which operates a multi-specialty hospital called "Kingsway Hospitals" with over 300 beds.

Existing promoters and stockholders will retain 49% ownership of the company. The hospital will be renamed "KIMS Kingsway Hospitals" upon the acquisition.

The existing hospital facilities provide the potential to increase bed capacity as needed in the future with minimum capital expenditure.

The transaction will be finalized with an infusion of Rs80 crore into the firm, which will be used to pay off current debts and partially to improve the Balance Sheet.

“KIMS' extensive expertise running multi-specialty hospitals and turning them around will enable the current purchase to swiftly achieve peak operational efficiency and create value for our shareholders,” stated company in media reports.

The transaction highlights the KIMS group's dedication and expertise to discovering possible acquisitions in designated areas using the Doctor partnership model and effectively collaborating with a varied collection of clinical/administrative skills.

The purchase is the second in the company's determined and well-articulated strategy to develop its footprint in Maharashtra through solid collaborations with local management and doctors.

At around 9.18 AM, Krishna Institute was trading 3.07% higher at Rs1,226.95 against previous close of Rs1190.35 on NSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • KIMSHospitalAcquisition
  • KIMSHospitalNews
  • KIMSHospitalShare
  • KIMSHospitalSharePrice
  • KIMSHospitalStock
  • KIMSHospitalStockPrice
  • KIMSHospitalUpdates
sidebar mobile

BLOGS AND PERSONAL FINANCE

Images
28 Mar 2024   |   03:36 PM
Images
28 Mar 2024   |   03:01 PM
Images
28 Mar 2024   |   01:21 PM
Images
28 Mar 2024   |   01:02 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.